CP(IB)No. 248/2018 was filed by the Proprietor of M/s Western Pharma under section 9 of the Insolvency and Bankruptcy Code, 2016, seeking reliefs under section 9 in respect of M/s. Osaka Pharmaceuticals Private Limited, treating it as a Corporate Debtor. The Adjudicating Authority admitted the CP(IB) No. 248/2017 on 10.10.2018 and appointed Shri Hiten M. Parikh as the Interim Resolution Professional (IRP). The CoC replaced the IRP in its first meeting held on 12.11.2018 and appointed Mr. Abhishek Nagori as the Resolution Professional (RP). The IRP made a public announcement on 15.10.2018 calling upon the claims from the creditors. The RP filed IA No. 439 of 2019 for liquidation of the Corporate Debtor Company Osaka Pharmaceuticals Limited under section 33(1) and 33(2)

CP(IB)No. 248/2018 was filed by the Proprietor of M/s Western Pharma under section 9 of the Insolvency and Bankruptcy Code, 2016, seeking reliefs under section 9 in respect of M/s. Osaka Pharmaceuticals Private Limited, treating it as a Corporate Debtor. The Adjudicating Authority admitted the CP(IB) No. 248/2017 on 10.10.2018 and appointed Shri Hiten M. Parikh as the Interim Resolution Professional (IRP). The CoC replaced the IRP in its first meeting held on 12.11.2018 and appointed Mr. Abhishek Nagori as the Resolution Professional (RP). The IRP made a public announcement on 15.10.2018 calling upon the claims from the creditors. The RP filed IA No. 439 of 2019 for liquidation of the Corporate Debtor Company Osaka Pharmaceuticals Limited under section 33(1) and 33(2)